Taunton

This trial is looking at volrustomig (MEDI5752) for head and neck cancer that has spread into the surrounding tissue and cannot be removed by surgery.

This trial is looking at a new drug called camizestrant for early breast cancer that has a medium to high risk of coming back.

This trial is comparing ibrutinib with, and without, treatment breaks. It is for people that have had ibrutinib for chronic lymphocytic leukaemia before.

This trial is comparing volrustomig and chemotherapy with standard treatment for mesothelioma of the lungs.

This study is looking at the long term benefits and risks of taking aspirin and esomeprazole to help prevent oesophageal cancer.

This study is looking at using small pieces of the DNA of bowel cancer that circulate in the blood (ctDNA) to work out whether the cancer might come back.

This trial is comparing datopotamab deruxtecan with and without durvalumab to chemotherapy and immunotherapy.

This trial is looking at bone marrow samples to help work out the best treatment for myeloma.

This trial is comparing a combination of 2 chemotherapy drugs with a combination of 3 chemotherapy drugs for bowel cancer.

This trial is looking at chemotherapy before surgery for bowel cancer to improve treatment.